Guidelines: Difference between revisions

From UrologySchool.com
Jump to navigation Jump to search
No edit summary
No edit summary
Line 37: Line 37:
==== Functional ====
==== Functional ====


* [[AUA: Management of LUTS Attributed to BPH (2021)|Management of LUTS Attributed to BPH (2021)]]
* '''NEW!''' [[AUA: Management of LUTS Attributed to BPH (2021)|Management of LUTS Attributed to BPH (2021)]]
*[[AUA & CUA Mesh Position Statement (2019)|AUA/CUA Mesh Position Statement (2019)]]
*[[AUA & CUA Mesh Position Statement (2019)|AUA/CUA Mesh Position Statement (2019)]]
* [[AUA: Incontinence after Prostate Therapy (2019)|Incontinence after Prostate Therapy (2019)]]
* [[AUA: Incontinence after Prostate Therapy (2019)|Incontinence after Prostate Therapy (2019)]]

Revision as of 20:33, 23 March 2023

AUA Guidelines

Oncology

Prostate

Bladder

Kidney

Testicular

  • (2019) Included in Testicular Tumours Chapter Notes

Non-oncology

Andrology

Functional

Infections and Inflammation

Pediatrics

Stones

Other

Contribute

  • Interstitial cystitis/bladder pain syndrome (2022)
  • Infertility (2021)
  • Priapism (2021)
  • Neurogenic LUTD (2021)
  • Disorders of ejaculation (2020)
  • OAB (2019)
  • Antibiotic Prophylaxis (2019)
  • Cryptorchidism (2018)

CUA Guidelines

Oncology

Prostate

Bladder

Kidney

Non-oncology

Andrology

Functional

Infections and Inflammation

Infertility

Pediatrics

Stones

Other

Contribute

  • Ureteral calculi (2022)
  • Pediatric bladder dysfunction (2021)
  • Sporadic angiomyolipomas (2020)
  • Male urethral stricture (2020)
  • Catheter use (2020)
  • Renal mass biopsy (2019)
  • Pheochromocytoma surveillance (2019)
  • Pediatric hemorrhagic cystitis (2019)